Ameriprise’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Ameriprise’s Portfolio LBPH Stock Details LBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-22,073	Closed	-$736K	–	4207
2024 Q3	$736K	Buy	22,073 +4,265	+24%	+$147K	﹤0.01%	3344
2024 Q2	$481K	Buy	17,808 +8,293	+87%	+$164K	﹤0.01%	3424
2024 Q1	$206K	Buy	+9,515	New	+$208K	﹤0.01%	3686

Ameriprise's LBPH Position: Q4 2024 in Review

Ameriprise sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 22,073 shares — an estimated $736K sold.

Ameriprise first reported a position in LBPH in Q1 2024 and held it in 3 quarters. The position peaked at $736K in Q3 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

Ameriprise reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Ameriprise sold 22,073 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $736K.
Ameriprise first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q1 2024 and held it in 3 quarters.
Ameriprise's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $736K in Q3 2024.
0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on Ameriprise's 13F filing for Q4 2024, filed 14 Feb 2025.